Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells (original) (raw)

Nature volume 518, pages 413–416 (2015)Cite this article

Subjects

Abstract

The role of cellular metabolism in regulating cell proliferation and differentiation remains poorly understood1. For example, most mammalian cells cannot proliferate without exogenous glutamine supplementation even though glutamine is a non-essential amino acid1,2. Here we show that mouse embryonic stem (ES) cells grown under conditions that maintain naive pluripotency3 are capable of proliferation in the absence of exogenous glutamine. Despite this, ES cells consume high levels of exogenous glutamine when the metabolite is available. In comparison to more differentiated cells, naive ES cells utilize both glucose and glutamine catabolism to maintain a high level of intracellular α-ketoglutarate (αKG). Consequently, naive ES cells exhibit an elevated αKG to succinate ratio that promotes histone/DNA demethylation and maintains pluripotency. Direct manipulation of the intracellular αKG/succinate ratio is sufficient to regulate multiple chromatin modifications, including H3K27me3 and ten-eleven translocation (Tet)-dependent DNA demethylation, which contribute to the regulation of pluripotency-associated gene expression. In vitro, supplementation with cell-permeable αKG directly supports ES-cell self-renewal while cell-permeable succinate promotes differentiation. This work reveals that intracellular αKG/succinate levels can contribute to the maintenance of cellular identity and have a mechanistic role in the transcriptional and epigenetic state of stem cells.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Lunt, S. Y. & Vander Heiden, M. G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27, 441–464 (2011)
    Article CAS PubMed Google Scholar
  2. Eagle, H., Oyama, V. I., Levy, M., Horton, C. L. & Fleischman, R. The growth response of mammalian cells in tissue culture to l-glutamine and l-glutamic acid. J. Biol. Chem. 218, 607–616 (1956)
    CAS PubMed Google Scholar
  3. Ying, Q. L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519–523 (2008)
    Article ADS CAS PubMed PubMed Central Google Scholar
  4. Nichols, J., Silva, J., Roode, M. & Smith, A. Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136, 3215–3222 (2009)
    Article CAS PubMed PubMed Central Google Scholar
  5. Smith, Z. D. et al. A unique regulatory phase of DNA methylation in the early mammalian embryo. Nature 484, 339–344 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
  6. Wray, J., Kalkan, T. & Smith, A. G. The ground state of pluripotency. Biochem. Soc. Trans. 38, 1027–1032 (2010)
    Article CAS PubMed Google Scholar
  7. Leitch, H. G. et al. Naive pluripotency is associated with global DNA hypomethylation. Nature Struct. Mol. Biol. 20, 311–316 (2013)
    Article CAS Google Scholar
  8. Ficz, G. et al. FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 13, 351–359 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  9. Habibi, E. et al. Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell 13, 360–369 (2013)
    Article CAS PubMed Google Scholar
  10. Borgel, J. et al. Targets and dynamics of promoter DNA methylation during early mouse development. Nature Genet. 42, 1093–1100 (2010)
    Article CAS PubMed Google Scholar
  11. Marks, H. et al. The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149, 590–604 (2012)
    Article CAS PubMed PubMed Central Google Scholar
  12. Ying, Q. L., Nichols, J., Chambers, I. & Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281–292 (2003)
    Article CAS PubMed Google Scholar
  13. Zhang, J., Nuebel, E., Daley, G. Q., Koehler, C. M. & Teitell, M. A. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11, 589–595 (2012)
    Article CAS PubMed PubMed Central Google Scholar
  14. Kaelin, W. G., Jr Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb. Symp. Quant. Biol. 76, 335–345 (2011)
    Article CAS PubMed PubMed Central Google Scholar
  15. Cloos, P. A., Christensen, J., Agger, K. & Helin, K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22, 1115–1140 (2008)
    Article CAS PubMed PubMed Central Google Scholar
  16. Kruidenier, L. et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488, 404–408 (2012)
    Article ADS CAS PubMed PubMed Central Google Scholar
  17. Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326 (2006)
    Article CAS PubMed Google Scholar
  18. Boyer, L. A. et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349–353 (2006)
    Article ADS CAS PubMed Google Scholar
  19. Mikkelsen, T. S. et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553–560 (2007)
    Article ADS CAS PubMed PubMed Central Google Scholar
  20. Blaschke, K. et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500, 222–226 (2013)
    Article ADS CAS PubMed PubMed Central Google Scholar
  21. Hackett, J. A. et al. Synergistic mechanisms of DNA demethylation during transition to ground-state pluripotency. Stem Cell Reports 1, 518–531 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  22. Faddah, D. A. et al. Single-cell analysis reveals that expression of Nanog is biallelic and equally variable as that of other pluripotency factors in mouse ESCs. Cell Stem Cell 13, 23–29 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  23. Shipony, Z. et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature 513, 115–119 (2014)
    Article ADS CAS PubMed Google Scholar
  24. Markoulaki, S., Meissner, A. & Jaenisch, R. Somatic cell nuclear transfer and derivation of embryonic stem cells in the mouse. Methods 45, 101–114 (2008)
    Article CAS PubMed Google Scholar
  25. Dawlaty, M. M. et al. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev. Cell 24, 310–323 (2013)
    Article CAS PubMed PubMed Central Google Scholar
  26. Buganim, Y. et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209–1222 (2012)
    Article CAS PubMed PubMed Central Google Scholar
  27. Millard, P., Letisse, F., Sokol, S. & Portais, J. C. IsoCor: correcting MS data in isotope labeling experiments. Bioinformatics 28, 1294–1296 (2012)
    Article CAS PubMed Google Scholar
  28. Yuan, J., Bennett, B. D. & Rabinowitz, J. D. Kinetic flux profiling for quantitation of cellular metabolic fluxes. Nature Protocols 3, 1328–1340 (2008)
    Article CAS PubMed PubMed Central Google Scholar
  29. Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917 (1959)
    Article CAS PubMed Google Scholar
  30. Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nature Protocols 8, 2281–2308 (2013)
    Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

B.W.C. is a Howard Hughes Medical Institute fellow of the Jane Coffin Childs Memorial Research Fund. L.W.S.F. is the Jack Sorrell Fellow of the Damon Runyon Cancer Research Foundation (DRG-2144-13). This work was funded by grants from the National Institutes of Health/National Institute of General Medical Sciences (C.D.A.) and from the National Cancer Institute (C.B.T.). We thank C. Li for assistance with FACS analysis and M. Dawlaty, D. Faddah and R. Jaenisch for sharing cell lines used in this study.

Author information

Author notes

  1. Bryce W. Carey and Lydia W. S. Finley: These authors contributed equally to this work.

Authors and Affiliations

  1. Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, 10065, New York, USA
    Bryce W. Carey & C. David Allis
  2. Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, 10065, New York, USA
    Lydia W. S. Finley & Craig B. Thompson
  3. Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, 10065, New York, USA
    Justin R. Cross

Authors

  1. Bryce W. Carey
    You can also search for this author inPubMed Google Scholar
  2. Lydia W. S. Finley
    You can also search for this author inPubMed Google Scholar
  3. Justin R. Cross
    You can also search for this author inPubMed Google Scholar
  4. C. David Allis
    You can also search for this author inPubMed Google Scholar
  5. Craig B. Thompson
    You can also search for this author inPubMed Google Scholar

Contributions

B.W.C. and L.W.S.F. designed and performed all experiments in the study under the guidance of C.D.A. and C.B.T. J.R.C. contributed material support. B.W.C., L.W.S.F., C.D.A. and C.B.T. wrote the manuscript.

Corresponding authors

Correspondence toC. David Allis or Craig B. Thompson.

Ethics declarations

Competing interests

C.B.T. is a co-founder of Agios Pharmaceuticals and a member of the board directors of Merck. C.D.A. is a co-founder of Chroma Therapeutics and Constellation Pharmaceuticals.

Extended data figures and tables

Extended Data Figure 1 Pluripotent stem cells can proliferate in the absence of glutamine when cultured in 2i/LIF medium.

a, Doubling time of ESC-V19 cells cultured in S/L or 2i/L. b, Growth curve of ESC-1 cells cultured in S/L or S/L/2i medium devoid of glucose. c, Samples of S/L (left) and 2i/L (right) media with and without glutamine were analysed by GC–MS. Representative chromatograms of the total ion count reveal a clear glutamine (Q) peak in +Q media (grey) and no detectable glutamine in −Q media (red). m, minutes. d, Teratoma formation from ES cells grown in 2i/L medium without glutamine for 3 days. Representative images of haematoxylin and eosin staining reveal neural tissue (ectoderm), hepatocytes and pancreatic acinar cells (endoderm) and smooth muscle (mesoderm). Scale bar, 200 μm. e, Growth curve of ESC-1 cells grown in glutamine-free 2i/L or 2i medium. f, Gene expression analysis confirms that EpiSCs, which represent post-implantation pluripotency, were generated from ESC-1 cells by culture with Fgf and activin A. Transcript levels were assessed by quantitative real-time polymerase chain reaction with reverse transcription (qRT–PCR), normalized to Gapdh and expressed as a ratio of values of mouse ES cells cultured in 2i/L medium. g, Growth curve of EpiSCs cultured in serum-free epiblast medium (serum-free medium containing FGF and activin A (Fgf/ActA)) with or without glutamine. h, Growth curve of an iPSC line derived from fibroblasts using Oct3/4 (O), Klf4 (K) and Sox2 (S) cultured in glutamine-free S/L or 2i/L medium. i, Doubling time of ESC-1 cells cultured in 2i/L medium in the presence and absence of glutamine. j, Growth curve of ESC-V19 cells cultured in glutamine-free 2i/L medium in the presence or absence of 1 mM methylsulphoxide (MSO). k, ESC-V19 cells grown in glutamine-free S/L (left) or 2i/L (right) medium with or without 4 mM DM-αKG. For growth curve experiments, cells were seeded on day 0 in complete medium and then were changed to experimental medium on day 1 (indicated by red arrow). Data are presented as the mean ± s.d. of triplicate wells from a representative experiment.

Extended Data Figure 2 Mouse ES cells cultured with 2i demonstrate altered glucose and glutamine utilization.

a, 2i enables glutamate synthesis from glucose-derived carbons. ESC-1 cells cultured in S/L, S/L/2i or 2i/L medium were incubated with medium containing [U-13C]glucose for 4 h and the fraction of glutamate containing glucose-derived carbons is shown. b, ESC-1 cells were cultured for 4 h in glutamine-free S/L or 2i/L medium containing [U-13C]glucose and the total amount of glutamate labelled by glucose-derived carbons is shown. c, Incorporation of 14C derived from [U-14C]glucose (14C-glc) (left) or derived from [U-14C]glutamine (14C-gln) (right) into total cellular protein after 48 h incubation. P < 0.05 for 14C-glc, P = 0.1 for 14C-gln, calculated by unpaired two-tailed Student’s _t-_test. Data are presented as the mean ± s.d. of triplicate wells (a, b) or ± s.e.m. of quadruplicate wells (c) from a representative experiment.

Extended Data Figure 3 Regulation of histone methylation in 2i/LIF cells.

a, Western blot analysis of ESC-1 cells grown in glutamine-free 2i/L medium for 24 h with supplementation as indicated. b, c, H3K27me3 ChIP-qPCR of ESC-1 cells cultured in S/L (b) or 2i/L (c) medium with or without 30 μM GSK-J4 for 5 h. Data are presented as the mean ± s.e.m. of triplicate samples. *P < 0.05 by unpaired Student’s two-tailed _t-_test.

Extended Data Figure 4 Generation of JMJD3 mutant cells.

a, Schematic of targeting strategy for guide RNAs (gRNAs) to mouse Jmjd3 exon 17. gRNA sequences are highlighted in blue. b, Representative sequences from two clones used in this study. Sanger sequencing revealed indels as shown in schematic. Red dashes, deleted bases; red bases, insertions. gRNA is highlighted in blue and protospacer adjacent motif (PAM) sequences are identified in green. Predicted cut site is indicated by red triangle. Location of in-frame downstream stop is indicated on the right. c, An example chromatogram for clone JMJD3Δ/Δ-2 showing single-base-pair insertions at the predicted Cas9 cleavage site.

Extended Data Figure 5 αKG increases Tet activity in mouse ES cells.

a, Simplified schematic of the reaction mechanism of Tet1/2 enzymes. b, Relative per cent 5-methylcytosine (% 5-mC) in ESC-1 cells cultured in S/L medium with or without DM-αKG for 24 h. Each data point represents a sample from triplicate wells of a representative experiment. c, Gene expression in ESC-1 cells cultured with DM-αKG or DM-succinate for 3 days. d, Gene expression in ESC-1 cells cultured in S/L medium with or without DM-αKG for four passages. e, Gene expression in wild-type or Tet1/Tet2 double-knockout (KO) mouse ES cells cultured with DM-αKG or DM-succinate for 72 h. qRT–PCR data (c–e) was normalized to actin or Gapdh and samples were normalized to the control group. Oct3/4 is not expected to change and is included as a control. Data are presented as the mean ± s.e.m. of triplicate wells.

Extended Data Figure 6 αKG increases Nanog expression.

a, Representative histogram of GFP intensity of Nanog–GFP cells treated with or without DM-αKG for 3 days. Grey represents background staining. b, ESC-1 cells were cultured in S/L medium with DM-αKG for four passages and then switched to medium containing the indicated amounts of DM-αKG (0.5–4 mM) or vehicle control (S/L) for 3 days. GFP expression (M.F.I.) was determined by fluorescence-activated cell sorting (FACS). Data are presented as the mean ± s.d. of triplicate wells from a representative experiment.

Supplementary information

PowerPoint slides

Rights and permissions

About this article

Cite this article

Carey, B., Finley, L., Cross, J. et al. Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells.Nature 518, 413–416 (2015). https://doi.org/10.1038/nature13981

Download citation

Editorial Summary

Alternative metabolism in stem cells

The role of cellular metabolism in regulating stem cell proliferation and differentiation has not been explored in great detail. Craig Thompson and colleagues now show that naive mouse embryonic stem cells can proliferate in the absence of exogenous glutamine, an amino acid normally essential for the growth of mammalian cells, while consuming it avidly when it is present. The cells catabolize glutamine and glucose to maintain high levels of downstream metabolites controlling chromatin modifications and DNA methylation, so as to ensure sufficient expression of pluripotency-associated genes.